hospital acquired infections

presented by
Daily

British diagnostics startup Atlas Genetics will use $20M Series C to start U.S. clinical trials for STI testing

Atlas Genetics, a British molecular diagnostics startup that creates rapid point-of-care tests for infectious diseases like chlamydia, will launch U.S. clinical trials with a $20 million Series C round. It will also expand its test offerings in the sexually transmitted infection and hospital acquired infection markets, Atlas said in a release. The company’s io(R) molecular diagnostic cartridge contains all the […]